Track I: Movement Disorders
Clinical Assessment of Drug-Induced Movement Disorders: A Case-Based Approach

Log in for full access to this session if you are registered.

Session Summary

This 2-hour, 2-part interactive presentation provides an excellent opportunity to gain a comprehensive review of drug-induced movement disorders for both new practitioners and experienced clinicians alike. Utilize movement disorder rating scales to be able to recognize and evaluate the signs and symptoms of pseudoparkinsonism, akathisia, and tardive dyskinesia.  Hone your clinical assessment skills with CPNP Movement Disorder DVD speakers Roger W. Sommi, Jr., and Steven C. Stoner in hour two of this session offering application of concepts via cases.

Faculty Information

Roger W. Sommi, Jr., PharmD, FCCP, BCPP
Steven C. Stoner, PharmD, BCPP

View biographical information and disclosures

Learning Objectives

  1. Describe the importance of proper training for effective rating scale use.
  2. Utilize the common rating scales for the assessment of drug-induced movement disorders.
  3. Given a specific patient case, delineate the use and selection of rating scales for assessment and monitoring.

Continuing Education Credit

Activity Date: 04/30/2012
ACPE Contact Hours: 1.0
ACPE Number: 0284-9999-12-010-L04-P (Application)
ACCME: 1 AMA PRA Category 1 Credit(s)™
Nursing Credit Reminder: Note that ACPE and ACCME credit is accepted for certification renewal.

Course Requirements

This session is presented live at the 2012 CPNP Annual Meeting. A PDF file of the slides is provided online. Access to the online PDF content is available to participants indefinitely although ACPE credit is available only through the Annual Meeting. To obtain continuing education credit, attendees of this session must confirm their attendance by completing a session evaluation within two weeks after the session. ACPE transcripts can be retrieved by participants online at cpnp.org and the credit will be automatically submitted to your account at CPE Monitor shortly after the evaluation is completed. CME statements will be issued by the end of June 2012 by the University of Arizona.